George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetra Diamonds Regulatory News (PDL)

Share Price Information for Petra Diamonds (PDL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.00
Bid: 43.50
Ask: 44.00
Change: 2.80 (6.80%)
Spread: 0.50 (1.149%)
Open: 42.00
High: 44.00
Low: 42.00
Prev. Close: 41.20
PDL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pricing of US$650 Million Notes Issue

6 Apr 2017 07:00

RNS Number : 7344B
Petra Diamonds Limited
06 April 2017
 

 

 

 

 

The information contained herein is not for publication or distribution, directly or indirectly, in or into the United States of America

 

 

This announcement contains inside information

 

6 April 2017

LSE: PDL

 

Petra Diamonds Limited

("Petra", "the Company" or "the Group")

 

Pricing of US$650 Million Notes Issue

 

 

Petra Diamonds Limited announces the pricing of its offering of senior secured second lien notes due 2022 (the "Notes"). The original offering amount of US$600 million has been increased to US$650 million. Interest on the Notes will accrue at the rate of 7.25% per annum, payable semi-annually in arrears. Closing is expected to take place on or about 12 April 2017, subject to customary conditions precedent for such transactions.

 

The Notes will be issued by Petra Diamonds US$ Treasury Plc, a wholly owned subsidiary of Petra Diamonds Limited.

 

Net proceeds from the Notes will be used to refinance the Company's existing US$300 million 8.25% senior secured second lien notes due 2020, to repay amounts outstanding under certain of the existing senior facilities (certain of which will be cancelled) and for general corporate purposes.

 

 

~ Ends ~

 

 

 

For further information, please contact:

 

Petra Diamonds, London Telephone: +44 20 7494 8203

Cornelia Grant cornelia.grant@petradiamonds.com

 

Buchanan Telephone: +44 20 7466 5000

(PR Adviser)

Bobby Morse bobbym@buchanan.uk.com

Anna Michniewicz annam@buchanan.uk.com

 

 

 

 

This announcement and the information contained herein are for information purposes only and do not constitute a prospectus or an offer to sell or a solicitation of an offer to buy or subscribe for any securities in the United States of America ("U.S.") or in any jurisdiction to persons to whom or in which jurisdiction such offer or solicitation is unlawful. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the laws of any state of the U.S., and may not be offered, sold or otherwise transferred in the U.S. absent registration or pursuant to an available exemption from registration under the Securities Act. Neither Petra Diamonds Limited nor its shareholder intends to register any securities referred to herein in the U.S.

 

Within the United Kingdom, this announcement is directed only at persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 ("relevant persons"). The investment or investment activity to which this announcement relates is only available to and will only be engaged in with relevant persons and person who receive this announcement who are not relevant persons should not rely or act upon it.

 

This announcement contains or incorporates by reference "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "projects", "expects", "intends", "aims", "plans", "predicts", "may", "will", "seeks", "could", "would", "shall" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and include statements regarding the intentions, beliefs or current expectations of the Group concerning, among other things, the Group's results of operations, financial condition, prospects, growth, strategies and the industries in which the Group operates.

 

By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future or are beyond the Group's control. Forward-looking statements are not guarantees of future performance and are based on one or more assumptions. The Group's actual results of operations and financial condition and the development of the industries in which the Group operates may differ materially from those suggested by the forward-looking statements contained in this announcement. In addition, even if the Group's actual results of operations, financial condition and the development of the industries in which the Group operates are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUVAARBRASRUR
Date   Source Headline
16th Apr 20247:00 amPRNQ3 FY 2024 Operating Update and Final Sales Results for Tender 5 FY 2024
9th Apr 20247:00 amPRNNotification of Q3 FY 2024 Operating Update
8th Apr 20247:00 amPRNCost savings target increased to more than US$30m per annum and entry into definitive transaction agreement for the sale of Koffiefontein.
8th Mar 20247:23 amPRNDirectorate Change
20th Feb 20247:00 amRNSH1 FY 2024 Interim Results
16th Feb 20247:00 amRNSFinal sales results for Tender 4 FY 2024
13th Feb 20247:00 amRNSNotification of H1 FY 2024 Interim Results
18th Jan 20247:00 amRNSDirector Share Awards
16th Jan 20247:00 amRNSH1 FY 2024 Operating Update
10th Jan 20247:00 amRNSNotification of H1 FY 2024 Operating Update
21st Dec 202310:40 amRNSDirectorate Change
20th Dec 20237:00 amRNSBoard Changes
14th Dec 20237:00 amRNSFinal sales results for Tender 3 FY 2024
13th Dec 202310:47 amRNSPotential Sale of Koffiefontein
8th Dec 20231:00 pmRNSHolding(s) in Company
8th Dec 202311:23 amRNSListing Rule 9.6.14 (R) Disclosure
8th Dec 20237:00 amRNSInitial sales results for Tender 3 FY 2024
8th Dec 20237:00 amRNSApproval of increase in Revolving Credit Facility
6th Dec 202312:25 pmRNSHolding(s) in Company
14th Nov 202311:06 amRNSResult of AGM
13th Nov 20232:45 pmRNSDirectorate Change
8th Nov 20234:03 pmRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSImproved resilience through capital deferrals
24th Oct 20233:21 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSQ1 FY 2024 Operating Update
19th Oct 20237:00 amRNSDirector Share Awards
19th Oct 20237:00 amRNSDirector Share Vesting
17th Oct 20237:01 amRNSNotification of Q1 FY 2024 Operating Update
17th Oct 20237:00 amRNSSales results for Tender 2 FY 2024
11th Oct 202310:54 amRNSHolding(s) in Company
10th Oct 20237:00 amRNSPublication of 2023 Reports and Notice of AGM
6th Oct 20237:00 amRNSInitial sales results for 75% of Tender 2 FY 2024
15th Sep 20237:01 amRNSDirectorate Change
15th Sep 20237:00 amRNSPreliminary Results for FY 2023
11th Sep 202311:10 amRNSShort delay of FY 2023 Preliminary Results
5th Sep 20237:00 amRNSNotification of FY 2023 Preliminary Results
25th Aug 20237:00 amRNSFirst tender of FY 2024 yields US$79.3m in sales
10th Aug 20232:15 pmRNSHolding(s) in Company
9th Aug 202310:04 amRNSHolding(s) in Company
18th Jul 20237:00 amRNSQ4 and FY 2023 Operating Update
12th Jul 20237:00 amRNSNotification of Q4 and FY 2023 Operating Update
28th Jun 20237:00 amRNSPublication of Presentation
7th Jun 20237:00 amRNSPostponement of Tender 6 FY 2023
31st May 20237:00 amRNSClass 2 Announcement
19th May 20234:00 pmRNSHolding(s) in Company
19th May 20237:00 amRNSSales results for Tender 5 FY 2023
9th May 20238:55 amRNSDirector Declaration
25th Apr 202310:00 amRNSHolding(s) in Company
24th Apr 202310:00 amRNSHolding(s) in Company
21st Apr 202310:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.